InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,275.90
(
0.58%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
86.51
(
1.64%
)
Bitcoin
63,013.32
(
0.66%
)
Post# of 252452
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 89977

Tuesday, 02/02/2010 7:12:34 AM

Tuesday, February 02, 2010 7:12:34 AM

Post# of 252452
Re: ACHN-elvucitabine

Elvucitabine will (IMO) never amount to anything of consequence commercially—in China or elsewhere.

I'm sure you will be right on this point. I think the partner for the compound is pretty telling itself of how little interest there was in licensing the compound. It's pretty clear that it's the success of the HCV compounds, not the non-HCV compounds, that will determine the fate of ACHN.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up